Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor?
- PMID: 30904025
- PMCID: PMC6431427
- DOI: 10.1186/s40249-019-0532-x
Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor?
Abstract
Background: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western China. The model focuses on increasing the reimbursement rate for TB patients and reforming provider payment methods by replacing fee-for-service with a case-based payment approach. This study investigated changes in out-of-pocket (OOP) health expenditure and the financial burden on TB patients before and after the interventions, with a focus on potential differential impacts on patients from different income groups.
Methods: Three sample counties in each of the three prefectures: Zhenjiang, Yichang and Hanzhong were chosen as study sites. TB patients who started and completed treatment before, and during the intervention period, were randomly sampled and surveyed at the baseline in 2013 and final evaluation in 2015 respectively. OOP health expenditure and percentage of patients incurring catastrophic health expenditure (CHE) were calculated for different income groups. OLS regression and logit regression were conducted to explore the intervention's impacts on patient OOP health expenditure and financial burden after adjusting for other covariates. Key-informant interviews and focus group discussions were conducted to understand the reasons for any observed changes.
Results: Data from 738 (baseline) and 735 (evaluation) patients were available for analysis. Patient mean OOP health expenditure increased from RMB 3576 to RMB 5791, and the percentage of patients incurring CHE also increased after intervention. The percentage increase in OOP health expenditure and the likelihood of incurring CHE were significantly lower for patients from the highest income group as compared to the lowest. Qualitative findings indicated that increased use of health services not covered by the standard package of the model was likely to have caused the increase in financial burden.
Conclusions: The implementation of the new financing and payment model did not protect patients, especially those from the lowest income group, from financial difficulty, due partly to their increased use of health service. More financial resources should be mobilized to increase financial protection, particularly for poor patients, while cost containment strategies need to be developed and effectively implemented to improve the effective coverage of essential healthcare in China.
Keywords: Case-based payment; Financing and payment model; Health insurance; Tuberculosis.
Conflict of interest statement
Ethics approval and consent to participate
Ethical approval of the study was issued by the Institutional Review Board of Chinese Center for Disease Control and Prevention. Consent form was obtained before individual data collection and could be provided upon request.
Consent for publication
Consent form was obtained before individual data collection and could be provided upon request.
Competing interests
The authors declare that they have no competing interests.
Figures
Similar articles
-
The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients.Infect Dis Poverty. 2019 Aug 2;8(1):67. doi: 10.1186/s40249-019-0575-z. Infect Dis Poverty. 2019. PMID: 31370909 Free PMC article.
-
Impact of an innovative tuberculosis financing and payment model on health service utilization by tuberculosis patients in China: do the poor fare better than the rich?Infect Dis Poverty. 2019 Jun 11;8(1):44. doi: 10.1186/s40249-019-0559-z. Infect Dis Poverty. 2019. PMID: 31182164 Free PMC article.
-
Inequity in healthcare needs, health service use and financial burden of medical expenditures in China: results from a consecutive household monitoring study in Jiangsu Province.BMC Health Serv Res. 2019 Dec 16;19(1):966. doi: 10.1186/s12913-019-4796-4. BMC Health Serv Res. 2019. PMID: 31842861 Free PMC article.
-
A New Financing Model for Tuberculosis (TB) Care in China: Challenges of Policy Development and Lessons Learned from the Implementation.Int J Environ Res Public Health. 2020 Feb 21;17(4):1400. doi: 10.3390/ijerph17041400. Int J Environ Res Public Health. 2020. PMID: 32098125 Free PMC article. Review.
-
Unblocking Barriers of Access to Hepatitis C Treatment in China: Lessons Learned from Tianjin.Ann Glob Health. 2020 Apr 6;86(1):36. doi: 10.5334/aogh.2763. Ann Glob Health. 2020. PMID: 32346522 Free PMC article. Review.
Cited by
-
Impact of diagnosis-related group payment on medical expenditure and treatment efficiency on people with drug-resistant tuberculosis: a quasi-experimental study design.Int J Equity Health. 2025 Jan 2;24(1):1. doi: 10.1186/s12939-024-02368-0. Int J Equity Health. 2025. PMID: 39748411 Free PMC article.
-
Impacts of Medical Security Level on Treatment Outcomes of Drug-Resistant Tuberculosis: Evidence from Wuhan City, China.Patient Prefer Adherence. 2022 Dec 20;16:3341-3355. doi: 10.2147/PPA.S389231. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 36573226 Free PMC article.
-
Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China.BMC Health Serv Res. 2023 Jan 26;23(1):89. doi: 10.1186/s12913-023-09078-3. BMC Health Serv Res. 2023. PMID: 36703175 Free PMC article.
-
How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers.Front Public Health. 2021 Nov 24;9:736632. doi: 10.3389/fpubh.2021.736632. eCollection 2021. Front Public Health. 2021. PMID: 34900894 Free PMC article.
-
Multichannel Financing Reduces Economic Burden and Improves the Medical Security Level for Tuberculosis Patients.China CDC Wkly. 2020 Mar 20;2(12):194-197. China CDC Wkly. 2020. PMID: 34594622 Free PMC article. No abstract available.
References
-
- WHO, Global Tuberculosis Report 2017. http://www.who.int/tb/publications/global_report/en/ (Accessed 23 Apr 2018).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical